US Patent Issued to Amgen on July 22 for "Thermostable compositions comprising live attenuated herpes simplex virus type 1" (California Inventor)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,723, issued on July 22, was assigned to Amgen Inc. (Thousand Oaks, Calif.).

"Thermostable compositions comprising live attenuated herpes simplex virus type 1" was invented by Enrique Alexander Flood (Simi Valley, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is a powder comprising a live, attenuated virus, recombinant human serum albumin (rHSA), a sugar other than lactose, a sugar alcohol, a source of phosphate, a source of chloride, wherein the composition is substantially free of lactose, gelatin, antibiotic, and free amino acids. In exemplary aspects, the powder is a lyophilizate of a liquid composition. Related liquid com...